Introduction to Immunity Part 2 All our MRD educational efforts are directed at the non-medical reader, but they also endeavor to be a true reflection... September 14, 2021The BasicsBy Brad Hedrick
Patient, Know Thyself Patient, Know Thyself Mark Hoffman is a long-time CLL patient advocate and facilitator of the CLL Society Patient & Caregiver Support... August 27, 2021Patient StoriesBy Brad Hedrick
Anemia in CLL (chronic lymphocytic leukemia) Anemia is a common problem in CLL and may be an indication to start treatment. However, it is not always... August 11, 2021Basic Terms and Hematology, The BasicsBy Brad Hedrick
Shingrix Approved in the US for Prevention of Shingles in Immunocompromised Adults Shingrix is a non-live safe vaccine that is very effective in preventing shingles, the potentially devastating painful reoccurrence of the... August 1, 2021TreatmentBy Brad Hedrick
Chronic Lymphocytic Leukemia (CLL), Ibrutinib and Fungal Infections Sad news. CLL Society just lost a member due to a fatal fungal blood infection that was not identified until the... July 16, 2021ComplicationsBy Brad Hedrick
ASH 2020: Dr. Furman Discusses Minimal Residual Disease-Driven Captivate and Murano Studies in Chronic Lymphocytic Leukemia (CLL) The treatment landscape for those of us with CLL/SLL has changed dramatically in the past decade or less. We see... June 24, 20212020 Conferences, MRD & Disease MonitoringBy Brad Hedrick
ASH 2020: Dr. Paolo Ghia on the Benefits of Individualized Treatment Plans for Chronic Lymphocytic Leukemia (CLL) At the annual meeting of the American Society of Hematology (ASH) 2020, our own Dr. Brian Koffman interviewed Dr. Paolo... June 17, 20212020 Conferences, MRD & Disease MonitoringBy Brad Hedrick
Introduction to Immunity All our MRD educational efforts are directed at the non-medical reader, but they also endeavor to be a true reflection... June 11, 2021The BasicsBy Brad Hedrick
ASH 2020: Dr. Jennifer Woyach on Triple Combination Therapy for Chronic Lymphocytic Leukemia (CLL) Bruton’s tyrosine kinase (BTK) inhibitors such as ibrutinib and acalabrutinib have been wonderfully effective drugs for treating chronic lymphocytic leukemia... June 2, 20212020 Conferences, MRD & Disease MonitoringBy Brad Hedrick
White Blood Cells and Differential for CLLers All our MRD educational efforts are directed at the non-medical reader, but they also endeavor to be a true reflection... March 22, 2021The BasicsBy Brad Hedrick
